Ortoma AB

  • Market Cap: Micro Cap
  • Industry: Hospital
  • ISIN: SE0005676103
SEK
9.64
1.24 (14.76%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Flat results in Sep 25

  • RAW MATERIAL COST(Y) Grown by 7,066.67% (YoY)
  • NET SALES(Q) Lowest at SEK 2.43 MM
  • OPERATING PROFIT(Q) Lowest at SEK -11.24 MM
2

Risky -

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Hospital

stock-summary
Market cap

SEK 300 Million (Micro Cap)

stock-summary
P/E

83.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.23

stock-summary
Return on Equity

-4.54%

stock-summary
Price to Book

1.82

Revenue and Profits:
Net Sales:
2 Million
(Quarterly Results - Sep 2025)
Net Profit:
-15 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-28.59%
0%
-28.59%
6 Months
-52.75%
0%
-52.75%
1 Year
3.66%
0%
3.66%
2 Years
-4.55%
0%
-4.55%
3 Years
25.19%
0%
25.19%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Ortoma AB for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
139.13%
EBIT Growth (5y)
5.79%
EBIT to Interest (avg)
-5.64
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.17
Sales to Capital Employed (avg)
0.29
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.35%
ROE (avg)
1.30%

Valuation key factors

Factor
Value
P/E Ratio
83
Industry P/E
Price to Book Value
2.85
EV to EBIT
63.36
EV to EBITDA
23.26
EV to Capital Employed
3.56
EV to Sales
5.46
PEG Ratio
0.69
Dividend Yield
NA
ROCE (Latest)
5.62%
ROE (Latest)
3.42%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
Bearish
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -75.76% vs 73.68% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -1,522.22% vs 52.63% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.40",
          "val2": "9.90",
          "chgp": "-75.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-11.20",
          "val2": "2.30",
          "chgp": "-586.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-14.60",
          "val2": "-0.90",
          "chgp": "-1,522.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-5,967.00%",
          "val2": "-73.40%",
          "chgp": "-589.36%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 28.87% vs 0.00% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 47.03% vs -38.61% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "49.10",
          "val2": "38.10",
          "chgp": "28.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.50",
          "val2": "1.80",
          "chgp": "-183.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.60",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-11.60",
          "val2": "-21.90",
          "chgp": "47.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-279.00%",
          "val2": "44.20%",
          "chgp": "-32.32%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoYstock-summary

Sep'25
Sep'24
Change(%)
Net Sales
2.40
9.90
-75.76%
Operating Profit (PBDIT) excl Other Income
-11.20
2.30
-586.96%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-14.60
-0.90
-1,522.22%
Operating Profit Margin (Excl OI)
-5,967.00%
-73.40%
-589.36%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Sep 2025 is -75.76% vs 73.68% in Sep 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is -1,522.22% vs 52.63% in Sep 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
49.10
38.10
28.87%
Operating Profit (PBDIT) excl Other Income
-1.50
1.80
-183.33%
Interest
0.00
0.60
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-11.60
-21.90
47.03%
Operating Profit Margin (Excl OI)
-279.00%
44.20%
-32.32%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 28.87% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 47.03% vs -38.61% in Dec 2023

stock-summaryCompany CV
About Ortoma AB stock-summary
stock-summary
Ortoma AB
Hospital
Ortoma AB is a Sweden-based company engaged in the medical technology. It develops an operation system for planning and positioning of joint implants in hip, knee and back surgery. The Company’s portfolio of products include Ortoma Treatment Solution, an integrated planning and measuring system, including a camera, navigation equipment and three-dimensional (3D) graphics for planning and performing prosthetic operations; Ortoma Plan, a preoperative planning system which allows surgeons to measure patient’s anatomy based on computer tomography or magnetic resonance, view it in 3D and plan operation and choice of implant before surgery; and Ortoma Guide, a navigation device which allows precise measurement and positioning of implants during operations. The Company cooperates with orthopedic departments at Sahlgrenska University Hospital, Skane University Hospital and Gothenburg University.
Company Coordinates stock-summary
Company Details
Falkenbergsgatan 3 8Tr , GOETEBORG None : 412 85
stock-summary
Tel: 46 31 7735163
stock-summary
Registrar Details